STEM: Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS

Sponsor
Kessler Foundation (Other)
Overall Status
Recruiting
CT.gov ID
NCT03983681
Collaborator
(none)
120
2
2
54.1
60
1.1

Study Details

Study Description

Brief Summary

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Strategy-Based Training to Enhance Memory (STEM)
  • Behavioral: Placebo control exercises
N/A

Detailed Description

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis (MS). The study is designed to research how well this technique can help people with MS improve their memory and their ability to function better in everyday life.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Masking Description:
Participants will be blind as to which treatment group they are being placed. Study staff conducting baseline and follow-up assessments will also be blind as to which group participants are placed. Study staff conducting intervention sessions will be blind to participants' baseline and follow-up assessment performance.
Primary Purpose:
Treatment
Official Title:
Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS
Actual Study Start Date :
Sep 26, 2019
Anticipated Primary Completion Date :
Feb 15, 2024
Anticipated Study Completion Date :
Mar 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental

The experimental group will receive memory enhancement exercises administered twice a week for 4 weeks (8 training sessions).

Behavioral: Strategy-Based Training to Enhance Memory (STEM)
Protocol designed to improve memory functioning in individuals with neurological injuries administered for 4 weeks (8 training sessions).

Placebo Comparator: Control group

The control group will receive placebo memory enhancement exercises administered twice a week for 4 weeks (8 training sessions).

Behavioral: Placebo control exercises
Placebo control memory exercises will be administered for 4 weeks (8 training sessions).

Outcome Measures

Primary Outcome Measures

  1. Changes in scores on self-report measure of everyday cognition (subjective) [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    Perceived Deficits Questionnaire

  2. Changes in scores on self-report measure of everyday cognition (objective) [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    Ecologic Memory Simulations

Secondary Outcome Measures

  1. Changes in auditory processing speed [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    Paced Auditory Serial Edition Test

  2. Changes in information processing speed [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    Symbol Digit Modalities Test

  3. Changes in episodic verbal memory and learning [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    California Verbal Learning Test - 2nd Edition

  4. Changes in visuospatial memory [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    Brief Visuospatial Memory Test - Revised

  5. Changes in ability in spontaneous production of words [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    Controlled Oral Word Association Test

  6. Changes in visual perception [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    Benton Judgment of Line Orientation

  7. Changes in executive function [Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)]

    Delis-Kaplan Executive Function System - Sorting

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 59 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of Multiple Sclerosis

  • Ability to read and speak English fluently

  • Difficulties with learning and memory skills

Exclusion Criteria:
  • Prior diagnosis of stroke or other neurological injury/disease

  • Flare up of symptoms within a month of study participation

  • History of significant psychiatric illness (e.g., bipolar disorder, schizophrenia, psychosis) or current diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder I or II

  • Current significant alcohol or substance abuse

  • Taking exclusionary medication (study team will review medications)

For Optional MRI:
  • Pacemaker or other implanted electrical device, brain stimulator, aneurysm clip (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and internal hearing aids [cochlear implants]), permanent eyeliner, implanted delivery pumps, or shrapnel fragments.

  • Dental implants

  • Left-handed

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kessler Foundation East Hanover New Jersey United States 07936
2 Kessler Rehabilitation Center Marlton New Jersey United States 08053

Sponsors and Collaborators

  • Kessler Foundation

Investigators

  • Principal Investigator: Nancy D Chiaravalloti, PhD, Kessler Foundation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kessler Foundation
ClinicalTrials.gov Identifier:
NCT03983681
Other Study ID Numbers:
  • R-1045-18
First Posted:
Jun 12, 2019
Last Update Posted:
Apr 6, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kessler Foundation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2020